GlucoSentient, a healthcare technology company, develops a personal glucose meter that allows diabetics to detect food contaminants.
GlucoSentient, Inc. develops personal glucose meters for diabetes patients around the globe. The company offers its products for therapeutic drug and heart health monitoring applications. It also offers test strips for detecting trace amounts of contaminates, such as bacteria, viruses, or chemical contamination in food. GlucoSentient, Inc. was incorporated in 2011 and is based in Champaign, Illinois.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 16, 2013 | Grant | $0.90M | 1 | National Science Foundation | — | Detail |
Jun 1, 2012 | Grant | $179.99K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |